EPAREL
eParel L.L.C. is the parent company of Bib & Tucker: a first-of-its-kind scalable, web-based uniform provider and management tool.
EPAREL
Social Links:
Industry:
SaaS Software
Founded:
2012-08-14
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.eparel.com
Total Employee:
1+
Status:
Active
Contact:
212-918-9129
Email Addresses:
[email protected]
Technology used in webpage:
Google Apps For Business Wix Wix DNS
Official Site Inspections
http://www.eparel.com
- Host name: 38.165.89.182
- IP address: 38.165.89.182
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "eParel"
EXPAREL | Non-opioid Analgesic Pain Management
EXPAREL ® (bupivacaine liposome injectable suspension) is indicated to produce postsurgical local analgesia via infiltration in patients aged 6 years and older and regional analgesia in โฆSee details»
Patient and practice resources - EXPAREL pro
5 days ago Important Safety Information. EXPAREL is contraindicated in obstetrical paracervical block anesthesia. Adverse reactions reported in adults with an incidence greater than or equal โฆSee details»
Products - Pacira
*The clinical benefit of the decrease in opioid consumption was not demonstrated in the pivotal trials. Results from a phase 4, double-blind, randomized, placebo-controlled trial that compared the efficacy and safety of EXPAREL 266 mg (20 โฆSee details»
ADVANCING RECOVERY WITH LONG-LASTING POSTSURGICAL
2 Single-dose, long-lasting EXPAREL as part of a multimodal approach, reduces postsurgical pain and can minimize the use of opioids* โข Eliminates the need for pumps and catheters thatcan โฆSee details»
eParel - Crunchbase Company Profile & Funding
EParel L.L.C. is the parent company of Bib & Tucker: a first-of-its-kind scalable, web-based uniform provider and management tool.See details»
Sevฤredent Sourcing Solutions and Pacira BioSciences
Sep 27, 2022 EXPAREL is not recommended to be used in patients younger than 6 years old for injection into the wound, for patients younger than 18 years old for injection near a nerve, โฆSee details»
EXPAREL - U.S. Food and Drug Administration
EXPAREL is intended for single-dose administration via infiltration to produce local analgesia and as a nerve block to produce regional analgesia. EXPAREL is available in dosage forms ofSee details»
Pacira Announces FDA Approval of Expanded EXPAREL Label to โฆ
Nov 10, 2023 In Part A, 66 subjects undergoing bunionectomy were randomized 1:1:1 to receive a sciatic nerve block in the popliteal fossa with a single dose of EXPAREL 266 mg, EXPAREL โฆSee details»
Exparel Injection: Uses, Dosage, Side Effects, Warnings
Nov 14, 2023 Exparel (bupivacaine) is an anesthetic (numbing medicine) that is used after surgery to provide local analgesia (pain relief in a small area) via infiltration for adults and children aged 6 and older and regional analgesia โฆSee details»
When will the EXPAREL patents expire, and when will
5 days ago Pacira BioSciences is optimistic about the future of EXPAREL and its other products. New Medicare reimbursement approvals for EXPAREL and iovera° starting in 2025 are โฆSee details»
DENTAL AND ORAL SURGERY RESOURCES FOR EXPAREL
EXPAREL is not recommended to be used in the following patient populations: patients <6 years old for infiltration, patients younger than 18 years old for interscalene brachial plexus nerve โฆSee details»
Exparel Market Size, Share, Trend, Forecast Report 2032
Dec 9, 2024 exparel market report overview The global Exparel Market size was USD 0.66 billion in 2023 and will touch USD 1.08 billion by 2032, exhibiting a CAGR of 5.2% during the โฆSee details»
Watch SK Conversations: Parentsโ Playbook for Pediatric
Dec 5, 2023 EXPAREL is not recommended to be used in patients younger than 6 years old for injection into the wound, for patients younger than 18 years old for injection near a nerve, โฆSee details»
Three Newly Approved Analgesics: An Update - PMC
Reprinted with permission from Kleinert R, Lange C, Steup A, Black P, Goldberg J, and Desjardins P. 16 Tapentadol IR is available in 50-mg, 75-mg, and 100-mg doses and is dosed โฆSee details»
EXPAREL | Non-opioid Analgesic Pain Management
5 days ago Important Safety Information. EXPAREL is contraindicated in obstetrical paracervical block anesthesia. Adverse reactions reported in adults with an incidence greater than or equal โฆSee details»
Exparel for Postoperative Pain Management: a Comprehensive โฆ
Oct 23, 2020 Exparel, a long-lasting liposomal bupivacaine local anesthetic agent, has many significant benefits in the management of postoperative pain. Overall, the literature suggests โฆSee details»
Exparel: Side effects, dosage, how long it lasts, uses, and more
Dec 12, 2021 Exparel (bupivacaine) is a brand-name injection used for pain relief as a nerve block or local analgesic. Learn about its side effects, dosage, and more.See details»
Pacira Announces FDA Approval of Expanded EXPAREL Label to
Oct 11, 2023 In Part A, 66 subjects undergoing bunionectomy were randomized 1:1:1 to receive a sciatic nerve block in the popliteal fossa with a single dose of EXPAREL 266 mg, EXPAREL โฆSee details»
The Benefits of a Multimodal Strategy Using Opioid-Reducing โฆ
Nov 2, 2022 Outcomes from a retrospective, single-center study on EXPAREL administered via local wound infiltration to patients undergoing laparoscopic colorectal surgery showed โฆSee details»
Oral Surgery Pain Management: The Opioid Free Option - EXPAREL
EXPAREL ® (bupivacaine liposome injectable suspension) is indicated to produce postsurgical local analgesia via infiltration in patients aged 6 years and older and regional analgesia in โฆSee details»